Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative levosimendan in impaired LV function patients undergoing CABG with cardiopulmonary bypass
TCTR20201120001Phase 4Completed
- Sponsor
- Chiang Mai University
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of levosimendan in coronary arteriosclerosis, left ventricular systolic dysfunction (LVSD), heart failure (HF), sponsored by Chiang Mai University. Started Feb 2019; status: completed.
02
Drugs
levosimendan
03
Conditions
coronary arteriosclerosisleft ventricular systolic dysfunction (LVSD)heart failure (HF)
Beyond the preview
Go deeper on TCTR20201120001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20201120001.